Knowledge Centre

The Cross-Sector Battery Systems Innovation Network, a community co-funded by Innovate UK and the Faraday Battery Challenge, held an in-person industry showcase on 26 March 2024 in Leicester to link the battery supply chain with a broad set of end-use sectors.

Hear how to upskill your business with insights into the benefits of AI standards. Learn about BSI’s pivotal role in the Innovate UK BridgeAI programme, unravelling support structures and activities tailored for SMEs across diverse sectors.

Join us for this in-person event which will bring the photonics and space communities together for a series of talks, networking and the opportunity to seek partners for collaboration.

A consortium building event to find out more about the Environmental Monitoring Innovation call, and to increase your chances of success by preparing you to apply for the opportunity.

Innovate UK in partnership with UK Science and Innovation (UK SIN) hosted an online event on 11 January 2024 to share invaluable insights gained from the Innovate UK Global Expert Mission (GEM) to Australia on Critical Materials for Electrification, which took place in March 2023.

Join the Innovate UK Transforming Medicines Manufacturing Community of Practice (TMM CoP) first Automation and Digitalisation webinar, to hear how small and medium enterprises (SMEs) are using innovative digital technologies to transform the medicines manufacturing industry.

Watch our briefing event, recorded 16 January 2024, to find out more about the Faraday Battery Challenge UKBIC SME credit competition.

The next round of the Creative Catalyst competition is due to launch in January 2024. Up to £10 million is available to fund innovations in a wide range of creative industries in the UK from architecture to animation and from fashion to film.

Innovate UK’s Cancer Therapeutics programme has funded a project to support the delivery of a software platform that analyses children’s reactions to chemotherapy in real time. By doing this, healthcare professionals will be equipped with the evidence needed to prescribe safer and more effective chemotherapy doses that are individually tailored to the patient, improving their long-term quality of life.